Lester Poon: Day 1 of ASCO24 was hectic, energizing, painful, and everything in between

Lester Poon, Chief Business Development Officer at Exactis Innovation, recently posted on LinkedIn:

“Day 1 of ASCO24 was hectic, energizing, painful, and everything in between. Kind of like a good romantic comedy.

It was great to see the cancer care community coming together to celebrate the latest innovations in cancer treatment. The common thread in our conversations was the need to provide patients with faster access to effective therapies. However, we understand that health systems are struggling with soaring costs and operational challenges.

At Exactis Innovation, we have focused our efforts on providing high-quality real-world insights to provincial payers and Canadian health organizations to help them make decisions on cancer care. So it was great to meet up with Goulven Theze from Unicancer to share experiences on working with pharma, biotech, payers, HTA bodies, and regulators to generate real-world evidence from real-world data. It is amazing what Unicancer has achieved. Looking forward to more opportunities to collaborate.

It is off to Day 2 of the American Society of Clinical Oncology (ASCO) Annual Meeting.”

Source: Lester Poon/LinkedIn